April 5, 2023

Dear OMIC Insureds:

We are pleased to announce new and updated risk management resources:

Our updated Anti-VEGF Medications for Adults presents suggestions to increase patient safety and decrease the likelihood of lawsuits related to these drugs. It also provides information about our sample consent documents for anti-VEGF agents, including new sample consent forms for two biosimilar drugs, Byooviz™ and Cimerli™ .
 
We also have a new sample consent form for the steroid injection, Xipere®.

Coming Soon: a new sample consent form for Syforvre™, a treatment for geographic atrophy (GA).

If you have questions, contact us for confidential risk management advice at riskmanagement@omic.com or call us at 1-800-562-6642 and enter 4 for Risk Management.

Sincerely,

Jane Mock, CPHRM, OMIC Risk Manager